Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

BACKGROUND: Early in the pandemic it was suggested that pre-existing use of non-steroidal anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with COVID-19. NSAIDs are an important analgesic, particularly in those with rheumatological disease, and are widely availab...

Descripción completa

Detalles Bibliográficos
Autores principales: Drake, Thomas M, Fairfield, Cameron J, Pius, Riinu, Knight, Stephen R, Norman, Lisa, Girvan, Michelle, Hardwick, Hayley E, Docherty, Annemarie B, Thwaites, Ryan S, Openshaw, Peter J M, Baillie, J Kenneth, Harrison, Ewen M, Semple, Malcolm G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104907/
https://www.ncbi.nlm.nih.gov/pubmed/33997800
http://dx.doi.org/10.1016/S2665-9913(21)00104-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104907/
https://www.ncbi.nlm.nih.gov/pubmed/33997800
http://dx.doi.org/10.1016/S2665-9913(21)00104-1

Ejemplares similares